Sweden· SE-20000727000011
DaTSCAN 74 MBq/ml Injektionsvätska, lösning
A medicinal product containing ioflupane (123i), registered in Sweden by GE Healthcare B.V..
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Ioflupane (123i)
- Manufacturer
- GE Healthcare B.V.
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20000727000011
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ioflupane (123i) in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDaTSCAN [I-123] 185MBq/2.5ml solution for injection vialsGE Healthcare Ltd
- CzechiaDATSCANGE Healthcare B.V., Eindhoven
- NetherlandsCelsunax 74 MBq/ml oplossing voor injectiePinax Pharma GmbH
- SwitzerlandDaTSCAN 123 I-Ioflupane
- FranceDATSCAN 74 MBq/ml, solution injectableGE HEALTHCARE (PAYS-BAS)
- United StatesDaTscanMedi-Physics Inc. dba GE Healthcare.
- GermanyIoflupan (123i) RotopRotop Radiopharmacy Gmbh
- CanadaDATSCANGE HEALTHCARE CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Ioflupan (123i) Rotop
- Belgium · Ioflupan (123i) Rotop, Ioflupane (123i) Rotop
- Czechia · Joflupan (123i) Rotop
- Germany · Ioflupan (123i) Rotop
- Finland · Joflupaani (123i) Rotop
- France · Ioflupane (123i) Rotop
- United Kingdom (Northern Ireland) · Datscan, Ioflupane (123i) Rotop
- Iceland · Datscan, Striascan
- Italy · Ioflupane (123i) Rotop
- Liechtenstein · Datscan
- Luxembourg · Ioflupane (123i) Rotop
- Netherlands · Joflupaan (123i) Rotop
- Norway · Datscan, Ioflupane (123i) Rotop
- Poland · Ioflupane (123i) Rotop
- Portugal · Ioflupano (123i) Rotop
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa8ed418-8006-4e01-af53-4aa71466cf7e GET /v1/drugs/aa8ed418-8006-4e01-af53-4aa71466cf7e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20000727000011",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20000727000011",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/datscan-epar-product-information_sv.pdf"
}See everything about ioflupane (123i).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.